APApyx Medical Corporation APYX NASDAQ · Healthcare · United States
$2.40 +0.42% +$0.01
- Market cap
- $100.7M
- Enterprise value
- $114.6M
- P/E
- -
- Forward P/E
- -
- PEG
- -
- P/S
- 1.7x
- P/FCF
- -
- EV/EBITDA
- -
- ROIC
- -6.8%
- Gross margin
- 34.5%
- Net margin
- -14.2%
- Dividend yield
- -
- Payout ratio
- -
- Net debt/EBITDA
- -
- Beta
- 1.31
- Free float
- 86.4%
About the company
Apyx Medical Corporation (APYX) is a company focused on the development and manufacturing of medical devices and technologies for aesthetic surgery and dermatology. Their main product is the J-Plasma® system, which combines radiofrequency energy with inert argon to create cold plasma for surgical procedures with minimal damage to surrounding tissues. This technology is utilized for various aesthetic procedures, including wrinkle removal, liposuction, skin rejuvenation, and more. Apyx Medical Corporation also focuses on developing and innovating in the field of dermatological and aesthetic medical devices to provide advanced solutions for physicians and their patients. Shares of Apyx Medical Corporation (APYX) could be suitable for investors who are tracking the healthcare sector and seeking investment opportunities in aesthetic surgery and dermatology.
Sector
Healthcare
Industry
Medical - Specialties
CEO
Charles D. Goodwin
Employees
205
Headquarters
Clearwater
Valuation
Is today's price reasonable?
- What to watch: The share price is above the Bulios Fair Price.
Growth and estimates
Is it growing, and what comes next?
- What speaks for it: It beat profit estimates 7 times in the last 8 quarters.
- What to watch: Revenue growth is slowing: 5.9% a year over the last 3 years against 14% over 5 years.
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
- What to watch: The company made a loss over the last 12 months.
Financial health
Can it carry its debt?
- What to watch: It passes only 3 of the 9 points of the Piotroski financial health test.
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number